Clinical Excellence Group Overview IHH Healthcare has embarked on a journey to improve clinical outcomes and enhance patient experience. Our wide-ranging initiatives include the introduction of clinical quality indicators, investing in new medical technologies, conducting service training and much more. Our efforts are aimed at ensuring patients feel cared for and costs are transparent at every touchpoint. 2. Providing continuous training for healthcare workers We actively promote and facilitate knowledge sharing across and within our markets. By drawing from each other’s successes and experiences, we can enhance efficiency, effectiveness, and performance of the entire organisation. The IHH Quality Summit is an annual event that marks our quality journey and accomplishments, while also honouring individuals who devote themselves to delivering exceptional care. At our eighth Quality Summit held in 2023, delegates across the IHH network, academics and industry experts gathered to explore the theme of ‘Future of Care’. At the event, we also introduced the Operational Excellence Symposium aimed at developing a ground-up culture of continuous improvement in advancing healthcare management. Separately in 2023, IHH Healthcare hosted four medical symposiums in India, Türkiye and Singapore to unite professionals across IHH, fostering collaboration across business units and driving collective growth and innovation. The symposiums, covering topics including organ transplants, oncology, reproductive medicine and robotics-assisted surgery, were a platform for sharing medical best practices and key advances, introducing attendees to capabilities across IHH and building a community to facilitate knowledge exchange and patient referrals. 3. Investing in new medical technologies and clinical offerings Mount Elizabeth Novena Hospital, a renowned private hospital in Singapore, opened its new Proton Therapy Centre in May 2023. The state-of-the-art facility is the first of its kind among private hospitals in Southeast Asia. It is also IHH Healthcare’s most substantial single investment in medical technology. Proton therapy painlessly and precisely targets tumours in sensitive areas like the head or the neck while minimising damage and radiation exposure to surrounding healthy tissues and organs. In other markets, we have also expanded our breadth and depth of medical services through the establishment of new treatment centres and introduction of advanced technologies such as artificial intelligence (AI) to improve disease diagnostics. 4. Adhering to a robust clinical governance framework IHH Healthcare’s commitment to excellent clinical and patient care is reflected in our adherence to a robust clinical governance framework. Through stringent quality standards, continuous monitoring, and evidencebased practices, we foster a culture of accountability, transparency, and continuous improvement, ultimately benefiting patients and stakeholders alike. Through this steadfast commitment, we uphold IHH’s reputation as a leader in the healthcare industry. 1. Tracking and measuring clinical performance and outcomes using clinical quality indicators Since the implementation of our Value-Driven Outcomes (VDO) strategy in Q4 2020, we have doubled our number of VDO procedures from four to eight, hence providing significantly more patients with high-quality and cost-efficient healthcare services. We started at a baseline of 113 clinical quality indicators (CQIs) in 2022 – our goal is to double this number by 2025. With growing CQIs, we can comprehensively and accurately track and monitor clinical performance and outcomes. An increase in CQIs usually co-relate with a lower outcome percentage, but IHH is striving to achieve a 90% target by 2025. This commitment to excellence is at the core of our mission. IHH Healthcare Berhad 6
RkJQdWJsaXNoZXIy NDgzMzc=